Targeting intracellular WT1 in AML with a novel RMF-peptide-MHC-specific T-cell bispecific antibody. Augsberger C, Hanel G, Xu W, Pulko V, et al. Blood 2021;138:2655-2669.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Augsberger C, Hanel G, Xu W, Pulko V, et al. Targeting intracellular WT1 in AML with a novel RMF-peptide-MHC-specific T-cell bispecific antibody. Blood 2021;138:2655-2669.
PMID: 34280257